Your Article Summary
See Latest ArticlesClinical trial: intragastric acid control in patients who have Barrett's oesophagus-comparison of once- and twice-daily regimens of esomeprazole and lansoprazole
Alimentary Pharmacology and Therapeutics, 07/01/09
Spechler SJ et al. - Esomeprazole 40 mg is significantly more effective than lansoprazole 30 mg in controlling intragastric pH with Barrett's oesophagus.
Related Articles
Grading of gastric foveolar-type dysplasia in Barrett's esophagus
Modern Pathology, 10/23/09
Relevance Score: 45%
"Glassy" Cells in Barrett's Mucosa
Anticancer Research, 11/11/09
Relevance Score: 44%
Prevalence of Barrett's Esophagus Remains Low in the Korean Population: Nationwide Cross-Sectional Prospective Multicenter Study
Digestive Diseases and Sciences, 10/06/09
Relevance Score: 42%
Imaging of subsquamous Barretts epithelium with ultrahigh-resolution optical coherence tomography: a histologic correlation study
Gastrointestinal Endoscopy, 10/23/09
Relevance Score: 40%
Radiofrequency Ablation of Barrett's Esophagus
Journal of Gastrointestinal Surgery, 10/13/09
Relevance Score: 40%
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner - meta-analysis of six randomized trials
Colorectal Disease, 12/09/09
Glutathione S-Transferase T1 (GSTT1) Gene Polymorphism and Gastric Cancer Susceptibility: A Meta-Analysis of Epidemiologic Studies
Digestive Diseases and Sciences, 12/09/09
A Randomized Controlled Trial of Double Versus Triple Therapy with Amantadine for Genotype 1 Chronic Hepatitis C in Latino Patients
Digestive Diseases and Sciences, 12/09/09